欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1313/006
药品名称
Oxikodon Depot Actavis
活性成分
oxycodone hydrochloride 40.0 mg
剂型
Prolonged-release tablet
上市许可持有人
Actavis Group PTC ehf., Iceland
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Denmark (DK)
Oxycodon "Actavis"
Iceland (IS)
Oxikodon Depot Actavis 40 mg Forðatafla
Norway (NO)
Reltebon Depot
Poland (PL)
Reltebon
Hungary (HU)
RELTEBON 40 mg retard tabletta
Bulgaria (BG)
Oxycodone Actavis
许可日期
2014/03/19
最近更新日期
2024/06/21
药物ATC编码
N02AA05 oxycodone
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_1313_006_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_1313_006_Final SPC
Date of last change:2024/09/06
PubAR
|
SE_H_1313_006_PAR
Date of last change:2024/09/06
PubAR Summary
|
SE_H_1313_006_PAR Summary
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase